ATLANTA -- The vast majority of U.S. obstetricians are unaware that a 1997 advisory warned that IgM-based tests for toxoplasmosis can have false-positive results.
In 1997, the Food and Drug Administration and the American College of Obstetricians and Gynecologists alerted physicians to this problem, which could result in misdiagnoses and inappropriate treatment.
But a September 1999 survey by the Centers for Disease Control and Prevention, which was completed by 476 U.S. obstetricians, found that 89% were unaware of the advisory
"I was shocked by the result," Dr. Jeffrey L. Jones said at an international conference on emerging infectious diseases sponsored by the CDC.
The exact incidence of false-positive toxoplasmosis test results would depend on the specific IgM test used and the prevalence of toxoplasmosis in a population of women.
A study published in 1997 reported that at least one IgM test had a specificity of 77.5%, Dr. Jones said in an interview
The 1997 FDA advisory told physicians to use both IgM and IgG tests as well as a clinical evaluation to correctly diagnose toxoplasmosis.
The 1999 survey was a follow-up to a 1998 CDC conference on preventing congenital toxoplasmosis and was designed to assess obstetricians' knowledge about the infection.
Among other findings, the survey determined that 7% of respondents had diagnosed at least one pregnant woman with toxoplasmosis during 1998.
Although all respondents said they counseled their patients to avoid cats while pregnant, 83% said they told patients to avoid raw or undercooked meat, 77% said they counseled on the correct handling of foods, and 68% said they counseled on the need for hand washing after gardening.
Universal screening for toxoplasmosis in pregnant women was opposed by 64% of the physicians who responded, because of the cost of universal screening, the relatively low incidence of infection in the United States, and the difficulty in interpreting test results.
Universal screening for toxoplasmosis is already done by 23% of respondents surveyed.
Two-thirds reported limiting screening of high-risk women, 47% said they screen women with suggestive symptoms, and 35% said they screen women who ask about toxoplasmosis, reported Dr. Jones, a medical epidemiologist with the CDC.
Based in part on these results, the CDC and ACOG will develop an educational program for toxoplasmosis.
The two organizations will also sponsor a cost-benefit analysis of routine patient screening and neonatal screening, Dr. Jones said at the conference, which was also sponsored by the American Society for Microbiology and the World Health Organization.
In a separate talk held at the conference, researchers from the Minnesota Department of Health presented the results of their findings from a serology screening of blood-bank donations conducted in October 1996.
The seroprevalence of toxoplasmosis infection was 9% in women aged 20-30 and 16% in those aged 31-40.
This finding suggests that exposure to toxoplasmosis continues throughout the child-bearing years.
Information on minimizing toxoplasmosis exposure must be distributed to women represented in these age groups, the researchers concluded.
COPYRIGHT 2000 International Medical News Group
COPYRIGHT 2001 Gale Group